Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors

被引:145
作者
Pronier, Elodie [2 ,3 ]
Almire, Carole [1 ,2 ,3 ,4 ]
Mokrani, Hayat [2 ,3 ]
Vasanthakumar, Aparna [5 ]
Simon, Audrey [2 ,3 ]
Mor, Barbara da Costa Reis Monte [2 ,3 ]
Masse, Aline [2 ,3 ]
Le Couedic, Jean-Pierre [2 ,3 ]
Pendino, Frederic [6 ,7 ]
Carbonne, Bruno [8 ]
Larghero, Jerome [9 ]
Ravanat, Jean-Luc [10 ]
Casadevall, Nicole [1 ,2 ,3 ,4 ]
Bernard, Olivier A. [3 ,11 ]
Droin, Nathalie [2 ,3 ]
Solary, Eric [2 ,3 ]
Godley, Lucy A. [5 ]
Vainchenker, William [2 ,3 ]
Plo, Isabelle [2 ,3 ]
Delhommeau, Francois [1 ,2 ,3 ,4 ]
机构
[1] Hop St Antoine, AP HP, Hematol Lab, F-75012 Paris, France
[2] Inst Gustave Roussy, INSERM, U1009, F-94805 Villejuif, France
[3] Univ Paris 11, Orsay, France
[4] Univ Paris 06, Paris, France
[5] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[6] INSERM, U1007, Paris, France
[7] Univ Paris 05, Paris, France
[8] Hop St Antoine, AP HP, Serv Gynecol Obstet, F-75012 Paris, France
[9] Univ Paris 07, Hop St Louis, Unite Therapie Cellulaire, Paris, France
[10] Commissariat Energie Atom, FRE CNRS 3200, Lab Les Acides Nucle, Grenoble, France
[11] Inst Gustave Roussy, INSERM, U985, F-94805 Villejuif, France
关键词
CHRONIC MYELOMONOCYTIC LEUKEMIA; MYELOID MALIGNANCIES; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; DNA METHYLATION; TET2; MUTATIONS; MUTANT TET2; JAK2; CELLS; FREQUENT;
D O I
10.1182/blood-2010-12-324707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TET2 converts 5-methylcytosine to 5-hydroxymethylcytosine (5-hmC) in DNA and is frequently mutated in myeloid malignancies, including myeloproliferative neoplasms. Here we show that the level of 5-hmC is decreased in granulocyte DNA from myeloproliferative neoplasm patients with TET2 mutations compared with granulocyte DNA from healthy patients. Inhibition of TET2 by RNA interference decreases 5-hmC levels in both human leukemia cell lines and cord blood CD34(+) cells. These results confirm the enzymatic function of TET2 in human hematopoietic cells. Knockdown of TET2 in cord blood CD34(+) cells skews progenitor differentiation toward the granulomonocytic lineage at the expense of lymphoid and erythroid lineages. In addition, by monitoring in vitro granulomonocytic development we found a decreased granulocytic differentiation and an increase in monocytic cells. Our results indicate that TET2 disruption affects 5-hmC levels in human myeloid cells and participates in the pathogenesis of myeloid malignancies through the disturbance of myeloid differentiation. (Blood.2011;118(9):2551-2555)
引用
收藏
页码:2551 / 2555
页数:5
相关论文
共 23 条
[1]   Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies [J].
Abdel-Wahab, Omar ;
Mullally, Ann ;
Hedvat, Cyrus ;
Garcia-Manero, Guillermo ;
Patel, Jay ;
Wadleigh, Martha ;
Malinge, Sebastien ;
Yao, JinJuan ;
Kilpivaara, Outi ;
Bhat, Rukhmi ;
Huberman, Kety ;
Thomas, Sabrena ;
Dolgalev, Igor ;
Heguy, Adriana ;
Paietta, Elisabeth ;
Le Beau, Michelle M. ;
Beran, Miloslav ;
Tallman, Martin S. ;
Ebert, Benjamin L. ;
Kantarjian, Hagop M. ;
Stone, Richard M. ;
Gilliland, D. Gary ;
Crispino, John D. ;
Levine, Ross L. .
BLOOD, 2009, 114 (01) :144-147
[2]   DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction [J].
Broeske, Ann-Marie ;
Vockentanz, Lena ;
Kharazi, Shabnam ;
Huska, Matthew R. ;
Mancini, Elena ;
Scheller, Marina ;
Kuhl, Christiane ;
Enns, Andreas ;
Prinz, Marco ;
Jaenisch, Rudolf ;
Nerlov, Claus ;
Leutz, Achim ;
Andrade-Navarro, Miguel A. ;
Jacobsen, Sten Eirik W. ;
Rosenbauer, Frank .
NATURE GENETICS, 2009, 41 (11) :1207-1215
[3]   Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis [J].
Delhommeau, Francois ;
Dupont, Sabrina ;
Tonetti, Carole ;
Masse, Aline ;
Godin, Isabelle ;
Le Couedic, Jean-Pierre ;
Debili, Najet ;
Saulnier, Patrick ;
Casadevall, Nicole ;
Vainchenker, William ;
Giraudier, Stephane .
BLOOD, 2007, 109 (01) :71-77
[4]   Mutation in TET2 in Myeloid Cancers [J].
Delhommeau, Francois ;
Dupont, Sabrina ;
Della Valle, Veronique ;
James, Chloe ;
Trannoy, Severine ;
Masse, Aline ;
Kosmider, Olivier ;
Le Couedic, Jean-Pierre ;
Robert, Fabienne ;
Alberdi, Antonio ;
Lecluse, Yann ;
Plo, Isabelle ;
Dreyfus, Francois J. ;
Marzac, Christophe ;
Casadevall, Nicole ;
Lacombe, Catherine ;
Romana, Serge P. ;
Dessen, Philippe ;
Soulier, Jean ;
Viguie, Franck ;
Fontenay, Michaela ;
Vainchenker, William ;
Bernard, Olivier A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22) :2289-2301
[5]   The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera [J].
Dupont, Sabrina ;
Masse, Aline ;
James, Chloe ;
Teyssandier, Irene ;
Lecluse, Yann ;
Larbret, Frederic ;
Ugo, Valerie ;
Saulnier, Patrick ;
Koscielny, Serge ;
Le Couedic, Jean Pierre ;
Casadevall, Nicole ;
Vainchenker, William ;
Delhommeau, Francois .
BLOOD, 2007, 110 (03) :1013-1021
[6]   Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation [J].
Ficz, Gabriella ;
Branco, Miguel R. ;
Seisenberger, Stefanie ;
Santos, Fatima ;
Krueger, Felix ;
Hore, Timothy A. ;
Marques, C. Joana ;
Andrews, Simon ;
Reik, Wolf .
NATURE, 2011, 473 (7347) :398-U589
[7]   Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation [J].
Figueroa, Maria E. ;
Abdel-Wahab, Omar ;
Lu, Chao ;
Ward, Patrick S. ;
Patel, Jay ;
Shih, Alan ;
Li, Yushan ;
Bhagwat, Neha ;
Vasanthakumar, Aparna ;
Fernandez, Hugo F. ;
Tallman, Martin S. ;
Sun, Zhuoxin ;
Wolniak, Kristy ;
Peeters, Justine K. ;
Liu, Wei ;
Choe, Sung E. ;
Fantin, Valeria R. ;
Paietta, Elisabeth ;
Lowenberg, Bob ;
Licht, Jonathan D. ;
Godley, Lucy A. ;
Delwel, Ruud ;
Valk, Peter J. M. ;
Thompson, Craig B. ;
Levine, Ross L. ;
Melnick, An .
CANCER CELL, 2010, 18 (06) :553-567
[8]   Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis [J].
Flach, Johanna ;
Dicker, Frank ;
Schnittger, Susanne ;
Kohlmann, Alexander ;
Haferlach, Torsten ;
Haferlach, Claudia .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03) :518-519
[9]   MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9 [J].
Gilles, Laure ;
Bluteau, Dominique ;
Boukour, Siham ;
Chang, Yunhua ;
Zhang, Yanyan ;
Robert, Thomas ;
Dessen, Philippe ;
Debili, Najet ;
Bernard, Olivier A. ;
Vainchenker, William ;
Raslova, Hana .
BLOOD, 2009, 114 (19) :4221-4232
[10]   Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification [J].
Ito, Shinsuke ;
D'Alessio, Ana C. ;
Taranova, Olena V. ;
Hong, Kwonho ;
Sowers, Lawrence C. ;
Zhang, Yi .
NATURE, 2010, 466 (7310) :1129-U151